RxDoctor Payments Data

Colin Burgess, DO

Orthopaedic Surgery · South Windsor, CTNPI 1689106304

Payments from drug & device makers

What this record shows

This record is dominated by grants: $27,500 of the $44,649 with a category attached, or 61.6%. 14 manufacturers reported payments, led by Arthrex at 47.8% of the total. Reporting peaked in 2022 at $38,185 and has fallen 99.7% since, to $113 in 2025. Among orthopaedic surgery clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,649in general payments, 2019–2025

Across 73 payments — averaging $611.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$21K
  • Fortis Surgical, LLC$9K
  • DJO, LLC$4K
  • Linvatec Corporation$4K
  • Medical Device Business Services, Inc.$3K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • plus $2K from 8 others

What the payments were for

  • Grants$27,50062%
  • Travel & lodging$4,32310%
  • Food & beverage$2,0265%
  • Education$10,80024%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,649 in reported general payments places this provider in the 90th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$66,117
Medicare patients
125
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone128$943
Meloxicam361$655
Diclofenac Sodium24$134
Gabapentin23$118
Cyclobenzaprine Hcl27$73
Oxycodone Hcl16$65
Tramadol Hcl13$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in South Windsor

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →